Creative Planning - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Creative Planning ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$62,000
-35.4%
40,018
+0.0%
0.00%
Q1 2021$96,000
+4700.0%
40,009
+2590.6%
0.00%
Q2 2017$2,0001,487
+16422.2%
0.00%
Q1 2017$090.0%0.00%
Q4 2016$090.0%0.00%
Q3 2016$090.0%0.00%
Q2 2016$090.0%0.00%
Q1 2016$090.0%0.00%
Q4 2015$090.0%0.00%
Q3 2015$09
-86.2%
0.00%
Q1 2015$0650.0%0.00%
Q4 2014$0650.0%0.00%
Q3 2014$0650.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 951,064$7,827,0004.06%
Wellington Shields Capital Management, LLC 855,056$7,037,0001.16%
Manatuck Hill Partners, LLC 15,090$124,0000.05%
Moors & Cabot, Inc. 22,935$187,0000.02%
Perceptive Advisors 43,682$360,0000.01%
ROYCE & ASSOCIATES LP 120,000$988,0000.01%
ALPS ADVISORS INC 125,015$1,029,0000.01%
MetLife Investment Management, LLC 26,316$217,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 136,518$1,124,0000.00%
Private Advisor Group, LLC 15,001$122,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders